Newton One Investments LLC Bristol Myers Squibb CO Transaction History

Newton One Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 20, 2023	BUY	$57.89 - $64.73 $636 - $712	11 Added 0.94%	1,180 $68,000
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $573 - $636	9 Added 0.78%	1,169 $74,000
Q4 2021 Jan 25, 2022	BUY	$53.63 - $62.52 $536 - $625	10 Added 0.87%	1,160 $72,000
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $473 - $554	8 Added 0.7%	1,150 $68,000
Q2 2021 Jul 16, 2021	BUY	$61.91 - $67.42 $557 - $606	9 Added 0.79%	1,142 $76,000
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $474 - $533	8 Added 0.71%	1,133 $72,000
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $64,957 - $73,608	1,125 New	1,125 $70,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Newton One Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Newton One Investments LLC with notifications on news.